We work across the oncology ecosystem — not just one corner of it.
Integrated Oncology Expertise
Oncology decisions are rarely made in isolation. A diagnostic result shapes a treatment path. An imaging finding informs a device decision. A patient's experience influences which treatment is chosen next. Understanding oncology today means understanding how all these pieces connect — which is why our expertise spans the full ecosystem, not a single discipline.
Cancer Screening & Diagnostics
From early detection to companion diagnostics, we help clients understand how screening and diagnostic innovations are evaluated, adopted, and reimbursed across the care pathway.
Imaging
Deep experience across oncology imaging modalities and the clinical and commercial decisions that shape their use in diagnosis, staging, and treatment monitoring.
Devices
Insight into the oncology devices that support diagnosis, treatment, and monitoring — and the stakeholders who decide when and how they're adopted.
Therapeutics
Our newest area of focus: helping therapeutics clients understand positioning, demand, and strategic communications in a landscape increasingly shaped by precision medicine with novel safety profiles that need new strategies.
HCP / KOL
Access to the physicians and key opinion leaders whose perspectives shape clinical adoption, guideline development, and treatment decisions.
Market Access / System Decision-Makers
Understanding of payers, health systems, pharmacists, C-suite executives, and the policy stakeholders who determine whether oncology innovation reaches the patients who need it.
Patient Perspective
The patient voice is central to oncology decision-making today — not as a checkbox, but as a lens. It's a perspective our own practice lead brings firsthand, as a cancer survivor and patient advocate, and one we build into every project alongside clinical and commercial data.
Diagnostics, imaging, devices, and therapeutics are converging.
Our expertise is built to move with them.